Source link : https://www.newshealth.biz/health-news/extension-data-reported-for-chronic-hand-eczema-treatment/
San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with chronic hand eczema. In a phase 3 extension study of patients with moderate to severe chronic hand eczema, presented as a late […]
Author : News Health
Publish date : 2024-04-12 13:42:35
Copyright for syndicated content belongs to the linked Source.